Income Statement Cytokinetics, Incorporated

Stocks

CYTK

US23282W6057

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 17:15:41 10/06/2026 BST			5-day change	1st Jan Change
67.45 ^USD	-1.46%		-4.37%	+6.42%

06-09	Cytokinetics, Incorporated Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-08-2026 09:18 AM
06-02	Cytokinetics Insider Sold Shares Worth $1,111,200, According to a Recent SEC Filing	MT

c44d0f87406645.zeJAOJjmNaak0U7DD-CnZ9hO2JLGCkXRbfv1X6BwJu0.oYUxTvXeBuDeuCy5PZL1Xp8ejePzQSadD4HGDOM6T7mh2ilRro900Mm-OQ

Published financial data: CYTOKINETICS, INCORPORATED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	70.43M	7.59M	7.53M	18.47M	88.04M
Other Revenues, Total	-	87M	-	-	-
Total Revenues	70.43M	94.59M	7.53M	18.47M	88.04M
Cost of Goods Sold, Total	160M	241M	330M	339M	416M
Gross Profit	-89.51M	-146M	-323M	-321M	-328M
Selling General & Admin Expenses, Total	96.8M	178M	174M	215M	284M
Other Operating Expenses, Total	96.8M	178M	174M	215M	284M
Operating Income	-186M	-324M	-496M	-536M	-612M
Interest Expense, Total	-29.33M	-51.16M	-57.67M	-86.51M	-104M
Interest And Investment Income	331K	11.34M	27.63M	51.53M	48.42M
Net Interest Expenses	-29M	-39.81M	-30.04M	-34.98M	-55.45M
Other Non Operating Income (Expenses)	-	-	-	-18.3M	4M
EBT, Excl. Unusual Items	-215M	-364M	-526M	-590M	-664M
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Legal Settlements	-	-	-	-	-
Other Unusual Items	-	-24.94M	-	-	-121M
EBT, Incl. Unusual Items	-215M	-389M	-526M	-590M	-785M
Earnings From Continuing Operations	-215M	-389M	-526M	-590M	-785M
Net Income to Company	-215M	-389M	-526M	-590M	-785M
Net Income - (IS)	-215M	-389M	-526M	-590M	-785M
Net Income to Common Incl Extra Items	-215M	-389M	-526M	-590M	-785M
Net Income to Common Excl. Extra Items	-215M	-389M	-526M	-590M	-785M
Per Share Items
Net EPS - Basic	-2.8	-4.33	-5.45	-5.26	-6.54
Basic EPS - Continuing Operations	-2.8	-4.33	-5.45	-5.26	-6.54
Basic Weighted Average Shares Outstanding	76.89M	89.82M	96.52M	112M	120M
Net EPS - Diluted	-2.8	-4.33	-5.45	-5.26	-6.54
Diluted EPS - Continuing Operations	-2.8	-4.33	-5.45	-5.26	-6.54
Diluted Weighted Average Shares Outstanding	76.89M	89.82M	96.52M	112M	120M
Normalized Basic EPS	-1.75	-2.53	-3.41	-3.29	-3.45
Normalized Diluted EPS	-1.75	-2.53	-3.41	-3.29	-3.45
Supplemental Items
EBITDA	-184M	-318M	-484M	-527M	-602M
EBITA	-186M	-324M	-496M	-536M	-612M
EBIT	-186M	-324M	-496M	-536M	-612M
EBITDAR	-	-	-	-	-
Total Revenues (As Reported)	70.43M	94.59M	7.53M	18.47M	88.04M
Normalized Net Income	-135M	-228M	-329M	-368M	-415M
Interest on Long-Term Debt	16.3M	19.1M	28.1M	32.8M	45.5M
Supplemental Operating Expense Items
General and Administrative Expenses	96.8M	178M	174M	215M	284M
Research And Development Expense From Footnotes	160M	241M	330M	339M	416M
Net Rental Expense, Total	-	-	-	-	-
Imputed Operating Lease Interest Expense	-	-	-	-	-
Imputed Operating Lease Depreciation	-	-	-	-	-
Stock-Based Comp., COGS (Total)	10.46M	19.1M	32.13M	44.01M	54.54M
Stock-Based Comp., G&A Exp. (Total)	16.37M	28.75M	39.93M	53.83M	57.75M
Total Stock-Based Compensation	26.83M	47.85M	72.06M	97.84M	112M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	113M	65.58M	113M	94.86M	123M
Short Term Investments	359M	717M	502M	981M	760M
Total Cash And Short Term Investments	472M	783M	615M	1.08B	882M
Accounts Receivable, Total	56.82M	147K	1.28M	16.65M	17.76M
Other Receivables	-	-	-	-	-
Total Receivables	56.82M	147K	1.28M	16.65M	17.76M
Prepaid Expenses	7.22M	12.46M	11.94M	15.28M	16.99M
Total Current Assets	536M	795M	628M	1.11B	917M
Gross Property Plant And Equipment	163M	180M	176M	178M	202M
Accumulated Depreciation	-16.19M	-17.09M	-28.35M	-37.18M	-47.3M
Net Property Plant And Equipment	146M	163M	148M	141M	155M
Long-term Investments	152M	46.71M	40.53M	145M	335M
Other Long-Term Assets, Total	7.19M	9.69M	8M	7.7M	17.34M
Total Assets	841M	1.01B	824M	1.4B	1.42B
Liabilities
Accounts Payable, Total	21.09M	25.61M	21.51M	20.37M	22.34M
Accrued Expenses, Total	34.37M	44.1M	42.64M	55.32M	83.28M
Short-term Borrowings	-	-	-	11.3M	31.1M
Current Portion of Long-Term Debt	-	-	10.08M	11.52M	41.18M
Current Portion of Leases	14.86M	13.83M	18.88M	19.18M	19.11M
Unearned Revenue Current, Total	-	-	-	52.37M	1.61M
Other Current Liabilities	1.54M	1.08M	9.57M	9.61M	3.83M
Total Current Liabilities	71.86M	84.62M	103M	180M	202M
Long-Term Debt	143M	610M	607M	769M	1.24B
Long-Term Leases	112M	128M	121M	113M	108M
Unearned Revenue Non Current	266M	301M	380M	462M	521M
Other Non Current Liabilities	4.46M	43K	33K	14M	13.7M
Total Liabilities	597M	1.12B	1.21B	1.54B	2.08B
Common Stock, Total	84K	94K	102K	118K	123K
Additional Paid In Capital	1.45B	1.48B	1.73B	2.56B	2.83B
Retained Earnings	-1.21B	-1.59B	-2.11B	-2.7B	-3.49B
Comprehensive Income and Other	-869K	-3.59M	-10K	2.4M	630K
Total Common Equity	244M	-108M	-386M	-135M	-660M
Total Equity	244M	-108M	-386M	-135M	-660M
Total Liabilities And Equity	841M	1.01B	824M	1.4B	1.42B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	84.86M	95.16M	103M	118M	123M
ECS Total Common Shares Outstanding	84.8M	94.83M	102M	118M	123M
Book Value / Share	2.88	-1.14	-3.8	-1.15	-5.37
Tangible Book Value	244M	-108M	-386M	-135M	-660M
Tangible Book Value Per Share	2.88	-1.14	-3.8	-1.15	-5.37
Total Debt	270M	751M	757M	923M	1.44B
Net Debt	-202M	-31.23M	142M	-153M	557M
Debt Equivalent Oper. Leases	-	-	-	-	-
Account Code - Inventory Valuation	3	-	3	3	3
Machinery, Total	27.48M	28.45M	28.16M	30.82M	35.32M
Full Time Employees	253	409	423	498	673

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-215M	-389M	-526M	-590M	-785M
Depreciation & Amortization - CF	2.28M	5.81M	11.89M	9.53M	10.12M
Depreciation & Amortization, Total	2.28M	5.81M	11.89M	9.53M	10.12M
(Gain) Loss From Sale Of Asset	-	-	-	45K	-
(Gain) Loss on Sale of Investments - (CF)	-	107K	35K	-19K	-25K
Asset Writedown & Restructuring Costs	2.84M	-	-	-	-
Stock-Based Compensation (CF)	26.83M	47.85M	72.06M	97.84M	112M
Other Operating Activities, Total	32.38M	60.37M	24.83M	50.58M	188M
Change In Accounts Receivable	-47.4M	56.67M	-1.14M	-15.37M	-1.11M
Change In Accounts Payable	1.06M	4.52M	-3.48M	-4.48M	2.66M
Change in Unearned Revenues	-	-87M	-	52.37M	-50.76M
Change in Other Net Operating Assets	54.8M	1.1M	7.71M	3.14M	13.58M
Cash from Operations	-143M	-300M	-414M	-396M	-510M
Capital Expenditure	-48.87M	-11.34M	-1.42M	-3.91M	-24.81M
Sale of Property, Plant, and Equipment	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-98.9M	-251M	241M	-549M	41.47M
Cash from Investing	-148M	-262M	239M	-553M	16.67M
Long-Term Debt Issued, Total	-	524M	-	-	729M
Total Debt Issued	-	524M	-	-	729M
Long-Term Debt Repaid, Total	-	-189M	-858K	-9.62M	-414M
Total Debt Repaid	-	-189M	-858K	-9.62M	-414M
Issuance of Common Stock	320M	17.54M	183M	760M	35.98M
Repurchase of Common Stock	-	-9.6M	-10.52M	-19.63M	-2.47M
Other Financing Activities, Total	-	174M	50M	200M	175M
Cash from Financing	320M	516M	221M	931M	524M
Foreign Exchange Rate Adjustments	-	-	-20K	209K	-715K
Net Change in Cash	29.68M	-45.48M	46.22M	-18.17M	30.4M
Supplemental Items
Cash Interest Paid	9.18M	15.16M	10.3M	25.97M	22.91M
Cash Income Tax Paid (Refund)	-	-	-	-	-
Levered Free Cash Flow	-180M	-127M	-261M	-241M	-380M
Unlevered Free Cash Flow	-161M	-95.08M	-225M	-187M	-315M
Change In Net Working Capital	25.29M	-65.22M	-2.27M	-44.27M	29.64M
Net Debt Issued / Repaid	-	335M	-858K	-9.62M	316M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-16.94	-21.83	-33.73	-30.11	-27.08
Return on Total Capital	-30.4	-35.02	-61.23	-57.92	-48.85
Return On Equity %	-120.54	-572.15	212.96	226	197.47
Return on Common Equity	-120.54	-572.15	212.96	226	197.47
Margin Analysis
Gross Profit Margin %	-127.09	-154.59	-4.28K	-1.74K	-372.55
SG&A Margin	137.45	188.16	2.31K	1.17K	322.89
EBITDA Margin %	-261.31	-336.6	-6.43K	-2.85K	-683.94
EBITA Margin %	-264.54	-342.75	-6.59K	-2.9K	-695.44
EBIT Margin %	-264.54	-342.75	-6.59K	-2.9K	-695.44
Income From Continuing Operations Margin %	-305.72	-411.21	-6.99K	-3.19K	-891.6
Net Income Margin %	-305.72	-411.21	-6.99K	-3.19K	-891.6
Net Avail. For Common Margin %	-305.72	-411.21	-6.99K	-3.19K	-891.6
Normalized Net Income Margin	-191.08	-240.53	-4.37K	-1.99K	-471.17
Levered Free Cash Flow Margin	-255.34	-134.32	-3.47K	-1.31K	-431.19
Unlevered Free Cash Flow Margin	-229.31	-100.52	-2.99K	-1.01K	-357.46
Asset Turnover
Asset Turnover	0.1	0.1	0.01	0.02	0.06
Fixed Assets Turnover	0.87	0.61	0.05	0.13	0.59
Receivables Turnover (Average Receivables)	2.21	0.27	10.53	2.06	5.12
Short Term Liquidity
Current Ratio	7.45	9.4	6.12	6.17	4.53
Quick Ratio	7.35	9.25	6	6.08	4.45
Operating Cash Flow to Current Liabilities	-1.98	-3.54	-4.04	-2.2	-2.52
Days Sales Outstanding (Average Receivables)	165.17	1.37K	34.66	177.64	71.34
Average Days Payable Outstanding	33.25	35.39	26.05	22.58	18.73
Long Term Solvency
Total Debt/Equity	110.69	-696.33	-195.93	-681.96	-218.13
Total Debt / Total Capital	52.54	116.77	204.25	117.18	184.65
LT Debt/Equity	104.59	-683.52	-188.43	-650.93	-204.28
Long-Term Debt / Total Capital	49.64	114.62	196.43	111.85	172.92
Total Liabilities / Total Assets	71.01	110.63	146.87	109.66	146.3
EBIT / Interest Expense	-6.35	-6.34	-8.6	-6.2	-5.89
EBITDA / Interest Expense	-5.72	-5.8	-8.4	-6.09	-5.8
(EBITDA - Capex) / Interest Expense	-7.39	-6.02	-8.42	-6.13	-6.04
Total Debt / EBITDA	-1.61	-2.53	-1.56	-1.75	-2.39
Net Debt / EBITDA	1.2	0.11	-0.29	0.29	-0.92
Total Debt / (EBITDA - Capex)	-1.25	-2.44	-1.56	-1.74	-2.3
Net Debt / (EBITDA - Capex)	0.93	0.1	-0.29	0.29	-0.89
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	26.15	34.3	-92.04	145.34	376.56
Gross Profit, 1 Yr. Growth %	117.66	63.36	120.61	-0.51	2.2
EBITDA, 1 Yr. Growth %	99.8	73	52.11	8.76	14.32
EBITA, 1 Yr. Growth %	98.33	74.01	53.05	8.07	14.17
EBIT, 1 Yr. Growth %	98.33	74.01	53.05	8.07	14.17
Earnings From Cont. Operations, 1 Yr. Growth %	69.15	80.65	35.3	12.03	33.15
Net Income, 1 Yr. Growth %	69.15	80.65	35.3	12.03	33.15
Normalized Net Income, 1 Yr. Growth %	69.15	69.06	44.57	12.03	12.58
Diluted EPS Before Extra, 1 Yr. Growth %	41.96	54.62	25.91	-3.44	24.14
Accounts Receivable, 1 Yr. Growth %	721.08	-99.74	772.79	1.2K	6.69
Net Property, Plant and Equip., 1 Yr. Growth %	799.87	11.46	-9.47	-4.58	10.07
Total Assets, 1 Yr. Growth %	57.61	20.62	-18.77	70.04	1.63
Tangible Book Value, 1 Yr. Growth %	115.08	-144.25	258.04	-64.96	387.27
Common Equity, 1 Yr. Growth %	115.08	-144.25	258.04	-64.96	387.27
Cash From Operations, 1 Yr. Growth %	-1.69K	110.15	38.33	-4.45	28.83
Capital Expenditures, 1 Yr. Growth %	342.2	-76.81	-87.51	175.85	535.1
Levered Free Cash Flow, 1 Yr. Growth %	160.62	-29.35	105.78	-7.25	57.33
Unlevered Free Cash Flow, 1 Yr. Growth %	260.25	-41.13	137.09	-16.45	68.09
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	61.9	30.16	-67.3	-55.81	241.93
Gross Profit, 2 Yr. CAGR %	22.9	88.57	89.84	48.15	0.83
EBITDA, 2 Yr. CAGR %	37.34	85.92	62.22	28.62	11.5
EBITA, 2 Yr. CAGR %	37.28	85.77	63.2	28.61	11.08
EBIT, 2 Yr. CAGR %	37.28	85.77	63.2	28.61	11.08
Earnings From Cont. Operations, 2 Yr. CAGR %	33.02	74.8	56.34	23.11	22.13
Net Income, 2 Yr. CAGR %	33.02	74.8	56.34	23.11	22.13
Normalized Net Income, 2 Yr. CAGR %	33.02	69.11	56.34	27.26	12.3
Diluted EPS Before Extra, 2 Yr. CAGR %	15.11	48.15	39.53	10.26	9.49
Accounts Receivable, 2 Yr. CAGR %	231.74	-85.43	-84.97	964.26	272.1
Net Property, Plant and Equip., 2 Yr. CAGR %	230.4	216.7	0.45	-7.06	2.49
Total Assets, 2 Yr. CAGR %	70.38	37.88	-1.02	17.53	31.46
Tangible Book Value, 2 Yr. CAGR %	372.2	-2.45	25.86	12.01	30.67
Common Equity, 2 Yr. CAGR %	372.2	-2.45	25.86	12.01	30.67
Cash From Operations, 2 Yr. CAGR %	25.21	478.72	70.5	14.97	10.95
Capital Expenditures, 2 Yr. CAGR %	331.98	1.27	-82.98	-41.3	318.56
Levered Free Cash Flow, 2 Yr. CAGR %	63.42	35.69	20.56	37.89	20.75
Unlevered Free Cash Flow, 2 Yr. CAGR %	79.3	45.63	18.12	40.43	18.44
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	30.76	52.12	-48.72	-35.99	-2.36
Gross Profit, 3 Yr. CAGR %	15.81	35.13	98.7	53.06	30.9
EBITDA, 3 Yr. CAGR %	28.04	48.32	73.89	41.98	23.66
EBITA, 3 Yr. CAGR %	27.96	48.57	74.15	42.25	23.61
EBIT, 3 Yr. CAGR %	27.96	48.57	74.15	42.25	23.61
Earnings From Cont. Operations, 3 Yr. CAGR %	26.53	47.3	60.5	39.9	26.37
Net Income, 3 Yr. CAGR %	26.53	47.3	60.5	39.9	26.37
Normalized Net Income, 3 Yr. CAGR %	26.53	44.09	60.5	39.9	22.17
Diluted EPS Before Extra, 3 Yr. CAGR %	12.76	27.01	40.33	23.42	14.71
Accounts Receivable, 3 Yr. CAGR %	103.07	-69.46	-42.98	-33.58	394.4
Net Property, Plant and Equip., 3 Yr. CAGR %	247	130	108.62	-1.25	-1.67
Total Assets, 3 Yr. CAGR %	58.53	51.85	15.59	18.55	11.97
Tangible Book Value, 3 Yr. CAGR %	111.07	114.47	50.48	-17.81	82.85
Common Equity, 3 Yr. CAGR %	111.07	114.47	50.48	-17.81	82.85
Cash From Operations, 3 Yr. CAGR %	12.08	48.8	259.16	40.57	19.41
Capital Expenditures, 3 Yr. CAGR %	280.24	62.97	-49.59	-56.93	29.83
Levered Free Cash Flow, 3 Yr. CAGR %	33.65	23.57	55.88	10.33	44.05
Unlevered Free Cash Flow, 3 Yr. CAGR %	37.7	23.7	71.29	5.09	49.05
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-7.92	47.9	-24.89	-7.22	9.54
Gross Profit, 5 Yr. CAGR %	16.33	13.71	41.12	40.2	51.48
EBITDA, 5 Yr. CAGR %	65.26	23.35	40.75	40.1	45.57
EBITA, 5 Yr. CAGR %	67.37	23.38	41.04	40.24	45.48
EBIT, 5 Yr. CAGR %	67.37	23.38	41.04	40.24	45.48
Earnings From Cont. Operations, 5 Yr. CAGR %	67.25	24.93	37.7	37.1	43.88
Net Income, 5 Yr. CAGR %	67.25	24.93	37.7	37.1	43.88
Normalized Net Income, 5 Yr. CAGR %	78.34	23.28	37.7	37.1	39.14
Diluted EPS Before Extra, 5 Yr. CAGR %	48.33	10.85	22.79	20.02	27.07
Accounts Receivable, 5 Yr. CAGR %	372.99	-33.28	-28.33	26.39	20.75
Net Property, Plant and Equip., 5 Yr. CAGR %	109.39	114.81	111.34	60.08	57
Total Assets, 5 Yr. CAGR %	37.67	28.05	31.31	37.06	21.69
Tangible Book Value, 5 Yr. CAGR %	20.91	-0.36	71.64	65.4	42.22
Common Equity, 5 Yr. CAGR %	20.91	-0.36	71.64	65.4	42.22
Cash From Operations, 5 Yr. CAGR %	30.97	24.1	32.56	34.21	124.5
Capital Expenditures, 5 Yr. CAGR %	98.25	31.55	9.76	8.32	17.55
Levered Free Cash Flow, 5 Yr. CAGR %	72.24	11.19	28.25	29.1	40.64
Unlevered Free Cash Flow, 5 Yr. CAGR %	64.16	8.19	29.5	30.13	47.66